Home / Resources / Head & Neck Cancer Awareness Month: US Patient Distributions – Geography, Age, Race, Gender & Income

Head & Neck Cancer Awareness Month: US Patient Distributions – Geography, Age, Race, Gender & Income

White paper
Clinical
''

Head and neck cancer (HNC) was responsible for 3.7% of new US cancer cases in 2020, and the National Cancer Institute estimated that 16,110 people nationally would die from the condition in 2024. Smoking and alcohol consumption, advanced age, and infectious diseases such as HPV are risk factors for HNC.

Related products
Digital map showcasing the reach of Sitetrove, providing data from trial sites across the globe.
Sitetrove
The industry-leading suite of global clinical trial investigator and site intelligence
Professional using a laptop device to access Trialtrove for trial insights and strategy.
Trialtrove
The go-to resource for informing clinical trial strategy, design and execution
Healthcare professional monitoring and analyzing R and D trends.
Pharmaprojects
The industry standard for tracking and analyzing the global drug R&D landscape

Related resources

Adoptive_Cell_Therapy
JAN 11, 2024
Infographic
Clinical

Adoptive Cell Therapy

Research in adoptive cell therapy has reached a new high in the past 5 years. See the number of trials initiated, top 3 companies, top 5 diseases & more.

ASCO 2024 Key Highlight
JUL 15, 2024
Infographic
Clinical

ASCO 2024 Key Highlights

This summary examines the clinical trial environment for industry-sponsored trials with data showcased at ASCO 2024.

cancer_vaccine_landscape_resource-card-thumbnail
NOV 10, 2023
Article
Commercial

Cancer Vaccines: Active Companies and Competitor Landscape

We take a look at the global cancer vaccine development landscape, which companies are developing vaccines, for which cancers, and in which geographies.

VIEW ALL